ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Rejection"

  • 2017 American Transplant Congress

    MicroRNAs Differentiate Between Antibody and T-Cell Mediated Renal Allograft Rejection.

    T. van den Bosch,1 M. Clahsen-van Groningen,2 F. Rezaee,3 D. Nieboer,4 E. Steyerberg,4 C. Baan,1 A. Rowshani.1

    1Internal Medicine, Section of Nephrology and Transplantation, Erasmus University Medical Center, Rotterdam, Netherlands; 2Pathology, Erasmus University Medical Center, Rotterdam, Netherlands; 3Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, Netherlands; 4Public Health, Erasmus University Medical Center, Rotterdam, Netherlands

    Purpose: MicroRNAs are important immune regulators of gene and protein expression. Both circulating and intragraft expression of microRNAs have been related to renal allograft rejection.…
  • 2017 American Transplant Congress

    Immune Activation and Rejection Risk in HIV-Positive Kidney Transplantation.

    S. Wisel, B. Shaw, L. Lee, K. Lee, C. Leung, P. Stock, Q. Tang.

    Division of Transplantation, University of California, San Francisco, San Francisco, CA

    Purpose: HIV+ kidney transplant recipients experience higher rates of rejection episodes when compared to HIV- recipients. We hypothesize that this early, aggressive rejection is associated…
  • 2017 American Transplant Congress

    C-C Chemokine Receptor 5 Polymorphisms and Risk of Antibody-Mediated Rejection in Renal Transplantation.

    J. Lee,1 D. Kim,1 J. Lee,1 S.-K. Kwon,1 S. Song,1 J. Lee,1 B. Kim,2 M. Kim,1 S. Kim,1 Y. Kim,1 K. Huh.1

    1Transplantation Surgery, Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea; 2Nephrology, Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea

    Antibody-mediated rejection (AMR) is the leading cause of graft failure after kidney transplantation. C-C Chemokine receptor 5 (CCR5) plays an important role in immune cell…
  • 2017 American Transplant Congress

    Early Rejection in the Elderly: Is It Predictable?

    J. Clark, T. Sparkes, B. Masters, S. Jonchhe, A. Haririan, B. Thomas, B. Ravichandran.

    University of Maryland Medical Center, Baltimore, MD

    Introduction: Optimal induction for elderly kidney transplant recipients (KTR) remains unclear. Older age may be associated with decreased immunogenicity; however, clinical heterogeneity of the elderly…
  • 2017 American Transplant Congress

    Time to First Therapeutic Tacrolimus Level: What Impact Does It Have After Heart Transplantation?

    O. Witkowsky, J. Teuteberg, C. Sciortino, M. Shullo.

    University of Pittsburgh Medical Center, Pittsburgh, PA

    Purpose: Appropriate time to therapeutic immunosuppression levels is not well defined. The purpose of this study is to investigate outcomes related to time to therapeutic…
  • 2017 American Transplant Congress

    Soluble Fibrinogen-Like Protein 2 Regulates Differentiation and Enhances Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Allograft Immunity.

    C. Yang, B. Peng, M. Xu, T. Zhu.

    Urology, Zhongshan Hospital, Fudan University, Shanghai, China

    Soluble fibrinogen-like protein 2 (sFGL2) is a novel immunoregulatory molecule, secreted mainly by regulatory T cells. CD11b+ Gr1+ myeloid-derived suppressor cells (MDSCs) are an important…
  • 2017 American Transplant Congress

    Pro Inflammatory Transitional B (TrB) Cells Characterize Renal Allograft Recipients with DSA and T Cell Mediated Rejection (TCMR).

    A. Sharma, A. Cherukuri, D. Rothstein.

    UPMC, Pittsburgh

    De novo DSA detected post-renal transplantation is associated with adverse outcomes. We have shown that de novo DSA is strongly associated with TCMR. In this…
  • 2017 American Transplant Congress

    Acute Antibody-Mediated Rejection in Pediatric Liver Transplantation.

    C. Eriksen,1 M. Zimmerman,1 J. Kim,1 S. Lerret,2 G. Telega,2 B. Vitola,2 J. Schiller,3 J. Hong.1

    1Dept. of Surgery, Division of Transplant, Medical College of Wisconsin, Milwaukee; 2Dept of Pediatrics, Division of Gastroenterology, Medical College of Wisconsin, Milwaukee; 3Director, Histocompatibility Laboratory, Medical College of Wisconsin, Milwaukee

    Donor-specific antibodies (DSA) and antibody mediated rejection (AMR) are associated with decreased graft survival in pediatric liver transplantation; however, the incidence of AMR is not…
  • 2017 American Transplant Congress

    Molecular Analysis of Acute Rejection in Formalin-Fixed Paraffin-Embedded Clinical Face Transplant Biopsies.

    T. Win,1 B. Dyring-Andersen,1 V. Barrera,2 S. Ho Sui,2 R. Lopdrup,1 H. Kiwanuka,1 N. Murakami,1 J. Teague,1 E. Lowry,1 E. Bueno,1 A. Chandraker,1 L. Riella,1 B. Pomahac,1 R. Clark.1

    1Brigham and Women's Hospital, Boston, MA; 2Harvard T.H. Chan School of Publich Health, Boston

    BackgroundDiagnosis of acute rejection in face transplants relies on the histological evaluation of allograft skin biopsies using BANFF classification, an approach with significant limitations including…
  • 2017 American Transplant Congress

    Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart Rejection.

    A. Loupy,1 J. Duong Van-Huyen,1 L. Hidalgo,2 J. Reeve,2 M. Racapé,1 O. Aubert,1 J. Venner,2 D. Viglietti,1 P. Bruneval,1 C. Lefaucheur,1 P. Halloran.2

    1Paris Translational Research Center for Organ Transplantation, Paris, France; 2University of Alberta, Edmonton, Canada

    Antibody-mediated rejection (AMR) is a major determinant of heart allograft loss. However, the specific effects of anti-HLA antibodies on heart allograft injury have not been…
  • « Previous Page
  • 1
  • …
  • 110
  • 111
  • 112
  • 113
  • 114
  • …
  • 172
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences